OphtiMed Rx Overview
OphtiMed Rx is developing a novel molecular therapy for dry age-related macular degeneration (AMD), a common eye disease leading to blindness. The company’s treatment protects retinal cells from senescence (cellular aging) and can halt the progression of dry AMD. OphtiMed Rx’s therapy is designed to prevent the loss of vision and independence caused by dry AMD, providing an enormous benefit to patients.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1.3M |
| Last funding | $1.3M |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.galilofek.com/ophtimedrx/ |
Locations
Afula, Israel
Qatsrin
Photos & Videos
No files yet
OphtiMed Rx Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesHealthcareLaboratoriesCore Technology
BiologicalsMoleculesTags (8)
pharmaceuticalspharma-companiesdrug-discoveryprivate-investorsophthalmologyinvestorseye-diseasesdrug-developmentOphtiMed Rx Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
OphtiMed Rx Lifecycle
Cumulative Funding Raised Over Time
All Events
OphtiMed Rx News
0 articlesNo news articles.
OphtiMed Rx Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 4 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
OphtiMed Rx Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | video or image, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Phone | 972526633794 |
| Creator | Dana Rabinovich |
| Creator email | dana@ophtimedrx.com |
| Last update | 2022-11-21T00:00:00.000Z |
| Created | 2022-11-21T00:00:00.000Z |
| Claimed | Yes |